Abstract
Although infectious endophthalmitis after intravitreal antivascular endothelial growth factor injections is rare, it is the most feared and potentially devastating complication of this procedure. There is no high-level evidence to provide definitive guidance on the management of endophthalmitis occurring after intravitreal injection (IVI). This clinical practice update reviews the published literature regarding post-IVI endophthalmitis and highlights areas in which further research is needed to better guide its management.
Original language | English (US) |
---|---|
Pages (from-to) | 443-451 |
Number of pages | 9 |
Journal | Journal of VitreoRetinal Diseases |
Volume | 6 |
Issue number | 6 |
DOIs | |
State | Published - Nov 1 2022 |
All Science Journal Classification (ASJC) codes
- Ophthalmology